MiRus announced new early feasibility study results supporting the use of its Siegel transcatheter aortic valve replacement ...

Transcatheter aortic valve implantation (TAVI) is now an established treatment option for elderly patients with severe ...

Traditional operative risk calculators, such as the European System for Cardiac Operative Risk Evaluation II (EuroSCORE II), ...

A true test of durability will take many more years, but if the valve holds up, it’s “potentially a game changer,” say ...

Permanent pacemaker rates were nearly 18% at 30 days but came down as sites gained experience with the new device.

About this study The objective of ENVISION is to evaluate the safety and effectiveness of the Navitor Transcatheter Aortic Valve Implantation (TAVI) System for treating patients with symptomatic, ...

TAVR is a quickly growing and readily available interventional therapy for severe, symptomatic aortic valve stenosis in patients who are either deemed inoperable or have a high degree of surgical ...

Aortic valve disease affects more than 26% of adult patients over 65 years of age 1; the main indication for aortic valve replacement (AVR) is aortic stenosis (AS), an active biological process with ...

Twelve percent of the entire cohort had moderate or greater TR at 1 year after transcatheter aortic valve implantation, suggesting that TR does not reliably respond to correction of aortic stenosis; ...

Valvular Heart Disease (VHD), is a major cause of mortality and morbidity. Even though echocardiography is the most accurate method of diagnosing VHD, not everyone has access to this equipment. It is ...

Objective To determine whether echocardiography-derived left ventricular filling pressure influences survival in patients with severe aortic stenosis (AS) undergoing aortic valve replacement (AVR).

Aortic stenosis (AS) is a progressive disease characterized by important interindividual variability in the rate of disease progression. The pathophysiology of AS progression is complex and involves ...